Consensus on the clinical impact of the new scientific evidence available on benign prostatic hyperplasia;Consenso sobre el impacto clínico de la nueva evidencia científica disponible sobre hiperplasia benigna prostática

Actas Urologicas Espanolas

Volumn 36, Issue 5, 2012, Pages 265-275

  Cozar Olmo J M ^a   Hernandez Fenandez C ^b   Minana Lopez B ^c   Amon Sesmero J H ^d   Montlleo Gonzalez M ^e   Rodriguez Antolin A ^f   Caballero Martinez F ^g  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL MORALES MESEGUER   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^e FUNDACIÓ PUIGVERT   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

Author keywords

Benign Prostatic Hyperplasia; Consensus; Delphi

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; HUMAN; MALE; PROSTATE HYPERTROPHY; QUESTIONNAIRE;

EVIDENCE-BASED MEDICINE; HUMANS; MALE; PROSTATIC HYPERPLASIA; QUESTIONNAIRES;

EID: 84860516374     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2012.01.004     Document Type: Article

References (52)

1. J.D. Mc Connell, C.G. Roehrborn, O.M. Bautista, G.L. Andriole, C.M. Dixon, and J.W. Kusek The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia N Engl J Med 349 2003 2387 2398 (Pubitemid 37542987)
2. C.G. Roehrborn, P. Siami, J. Barkin, R. Damião, K. Major-Walker, I. Nandy on behalf of the CombAT Study Group The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study Eur Urol 57 2010 123 131
3. C.G. Roehrborn, J. Barkin, P. Siami, A. Tubaro, T.H. Wilson, and B.B. Morrill Clinical outcomes after combination therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsuolsin (CombAT) trial BJU Int 107 2011 946 954
4. N.C. Dalkey The Delphi Method: an experimental study of group opinion 1969 Rand Corporation Santa Monica (California)
5. E.A. Holey, J.L. Feeley, J. Dixon, and V.J. Whittaker An exploration of the use of simple statistics to measure consensus and stability in Delphi studies BMC Med Res Methodol 7 2007 52
6. Miñana B, Layola M, Prieto M. Distribución de severidad clínica y prevalencia de criterios de progresión en Consultas de Urología de pacientes con Hiperplasia Benigna de próstata en España. Actas Urol. 2009;Suppl XXXIII: Abstract C-41.
7. T.J. Peters, J.L. Donovan, H.E. Kay, P. Abrahams, J.J. De la Rosette, and D. Porru The International Continence Society "Benign Prostatic Hyperplasia" study: the botherosomeness of urinary symptoms J Urol 157 1997 885 889 (Pubitemid 27066273)
8. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MJ, et al. European Association of Urology (EAU). Guidelines on Conservative Treatment of Non-neurogenic Male LUTS. 2010.
9. NICE- The management of lower urinary tract symptoms in men. 2010 [consultado Feb 2012]. Disponible en: http://www.nice.org.uk/guidance/CG97/ FullGuidance
10. F.J. Castiñeiras, J.M. Cozar Olmo, A. Fernandez-Pro, J.A. Martin, F.J. Brenes Bermudez, and P.E. Naval Criterios de derivación en hiperplasia benigna de próstata para atención primaria Actas Urol Esp 34 2010 24 34
11. Cózar JM, Castiñeiras J, en representación del Comité Científico de Criterios de Derivación en Hiperplasia Benigna de Próstata, Madrid. Criterios de derivación de la hiperplasia benigna de próstata para atención primaria. Versión 2011. Actas Urol Esp. 2012;36:203-4.
12. M. Naslund, M.T. Eaddy, S.L. Hogue, E.J. Kruep, and M.B. Shah Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery Curr Med Res Opin 25 2009 2663 2669
13. European Association of Urology (EAU). Guidelines on Conservative Treatment of Non-neurogenic Male LUTS. 2010 [consultado Feb 2012]. Disponible en: http://www.uroweb.org/gls/pdf/BPH%202010.pdf
14. American Urological Association (AUA). Benign Prostatic Hyperplasia (BPH) (2010) [consultado Feb 2012]. Disponible en: http://www.auanet.org/content/ guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph
15. S. Yang, W.C. Lin, H.K. Chang, J.M. Hsu, W.R. Lin, and Y.C. Chow Gyrusplasmasect: is it better than monopolar transurethral resection of prostate? Urol Int 73 2004 258 261 (Pubitemid 39482708)
16. H. Singh, M.R. Desai, P. Shrivastav, and K. Vani Bipolar versus monopolartransuretral resection of prostate: randomized controlled study J Endourol 19 2005 333 338 (Pubitemid 40656308)
17. J.S. Starkman, and R.A. Santucci Comparison of bipolar transurethral resection of the prostate with standard transuretral prostatectomy: shorter stay, earlier catheter removal and feder complications BJU Int 95 2005 69 71 (Pubitemid 350020872)
18. I. Seckiner, C. Yesilli, B. Akduman, K. Altan, and N.A. Mungan A prospective randomized study for comparing bipolar plasmakinetic resection of the prostate with standard TURP Urol Int 76 2006 139 143 (Pubitemid 43872563)
19. C.J. Yoon, J.Y. Kim, K.H. Moon, H.C. Jung, and T.C. Park Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome Yonsei Med J 47 2006 715 720
20. M. De Sio, R. Autorino, G. Quarto, R. Damiano, S. Perdonà, and G. Di Lorenzo Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial Urology 67 2006 69 72 (Pubitemid 43069258)
21. H. Ho, S. Yip, and K.T. Foo A hybrid technique using bipolar energy in transuretral prostate surgery: a prospective, randomized comparison J Urol 175 2006 1965 1966
22. H.S. Ho, S.K. Yip, K.B. Lim, S. Fook, K.T. Foo, and C.W. Cheng A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using system Eur Urol 52 2007 517 522
23. R. Autorino, R. Damiano, G. Di Lorenzo, G. Quarto, S. Perdonà, and M. DArmiento Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate Eur Urol 55 2009 922 929
24. C. Qi, Z. Li, F. Qi-Liang, Z. Juan, P. Yu-Bing, and W. Zhong Bipolar transurethral resection in saline vs traditional monopolar resection of theprostate: results of a randomized trial with a 2-year follow-up BJU Int 12 2011 56 61
25. T. Fagerström, C.R. Nyman, and R.G. Hahn Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients BJU Int 105 2009 1560 1564
26. P.J. Gilling, M. Mackey, M. Cresswell, K. Kennett, J.N. Kabalin, and M.R. Fraundorfer Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup J Urol 162 1999 1640 1644 (Pubitemid 29474680)
27. R.M. Kuntz, S. Ahyai, K. Lehrich, and A. Fayad Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients J Urol 172 2004 1012 1016 (Pubitemid 39096451)
28. F. Montorsi, R. Naspro, A. Salonia, N. Suardi, A. Briganti, and M. Zanoni Holmium laser enucleation versus trans-urethral resection of the prostate: results from a two-centre prospective randomized trial in patients with obstructive benign prostatic hyperplasia J Urol 172 2004 1926 1929 (Pubitemid 39363092)
29. R. Naspro, M. Freschi, A. Salonia, G. Guazzoni, V. Girolamo, and R. Colombo Holmium laser enucleation (HoLEP) versus trans-urethral resection (TURP) of the prostate: are histological findings comparable? J Urol 171 2004 1203 1206 (Pubitemid 38327559)
30. A.H. Tan, P.J. Gilling, K.M. Kennett, C. Frampton, A.M. Westenberg, and M.R. Fraundorfer A randomized trial comparing holmium laser enucleation of the prostate with transuretral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams) J Urol 170 2003 1270 1274 (Pubitemid 37108129)
31. S.A. Ahyai, K. Lehrich, and R. Kuntz Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial Eur Urol 52 2007 1456 1464 (Pubitemid 47445981)
32. L.C. Wilson, P.J. Gilling, A. Williams, K.M. Kennet, C.M. Frampton, and A.M. Westenberg A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years Eur Urol 50 2006 569 573 (Pubitemid 44189064)
33. A. Westenberg, P. Gilling, K. Kennett, C. Frampton, and M. Fraundorfer Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup J Urol 172 2004 616 619 (Pubitemid 38900219)
34. J.A. Moody, and J.E. Lingeman Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy J Urol 165 2001 459 462 (Pubitemid 32060436)
35. R. Naspro, N. Suardi, A. Salonia, V. Scattoni, G. Guazzoni, and R. Colombo Holmium laser enucleation of the prostate versus open prostatectomy for Prostates >70 g: 24-Month Follow-up Eur Urol 50 2006 563 568 (Pubitemid 44189063)
36. R.M. Kuntz, and K. Lehrich Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm. A randomized prospective trial of 120 patients J Urol 168 2002 1465 1469 (Pubitemid 35034148)
37. A. Bachmann, L. Schurch, R. Ruszat, S.F. Wyler, H.H. Seifert, and A. Müller Photoselective vaporization (PVP) versus transuretral resection of the prostate (TURP): a prospective bi-center study of perioperative morbidity and early functional outcome Eur Urol 48 2005 965 969
38. R. Ruszat, S.F. Wyler, M. Seitz, K. Lehmann, C. Abe, and G. Bonkat Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study BJU Int 102 2008 1432
39. D.M. Bouchier-Hayes, P. Anderson, S. van Appledorn, P. Bugeja, and A.J. Costello KTP laser versus transurethral resection: early results of a randomized trial J Endourol 20 2006 580 585 (Pubitemid 44689646)
40. K. Horasanli, M.S. Silay, B. Altay, O. Tanriverdi, K. Sarica, and C. Miroglu Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostate larger than 70 ml: a shortterm prospective randomized trial Urology 71 2008 247 251 (Pubitemid 351282348)
41. S.R. Keoghane, K.C. Lawrence, A.M. Gray, H.A. Doll, A.M. Hancock, and K. Turner A double blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3 year follow-up BJU Int 85 2000 74 78 (Pubitemid 30072453)
42. G. Alivizatos, A. Skolarikos, D. Chalikopoulos, C. Papachristou, O. Sopilidis, and A. Dellis Transurethralphotoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study Eur Urol 58 2008 427 437
43. C. Capitán, C. Blázquez, M.D. Martin, V. Hernández, E. de la Peña, and C. Llorente GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up Eur Urol 60 2011 734 739
44. J.H. Amón Sesmero, J.M. Martínez-SagarraOceja, J. Estebanez Zarranz, A. Rodríguez Toves, F. Del Río Domínguez, and M.C. Velasco Permanent endoprostatic prostheses in patient with obstruction caused by benign hyperplasia of the prostate Actas Urol Esp 22 1998 490 497
45. J.V. Jepsen, and R.C. Bruskewitz Recent developments in the surgical management of benign prostatic hyperplasia Urology 51 1998 23 31 (Pubitemid 28189130)
46. I. Varkarakis, Z. Kyriakakis, A. Delis, V. Protogerou, and C. Deliveliotis Long-term results of open transvesical prostatectomy from a contemporary series of patients Urology 64 2004 306 310 (Pubitemid 39092460)
47. O. Reich, C. Gratzke, and C.G. Stief Techniques and long-term results of surgical procedures for BPH Eur Urol 49 2006 970 978 (Pubitemid 43674012)
48. T. Lourenzo, M. Shaw, C. Fraser, G. Maclennam, J. NDow, and R. Pickard The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomized controlled trials World J Urol 28 2010 23 32
49. O. Reich, C. Gratzke, A. Bachmann, B. Seitz, B. Schlenker, and P. Hermanek Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10.654 patients J Urol 180 2008 246 249
50. J. Zargooshi Open prostatectomy for benign prostate hyperplasia: short-term outcome in 3,000 consecutive patients Prostate Cancer Prostatic Dis 10 2007 374 377 (Pubitemid 350238087)
51. C. Gratzke, B. Schlenker, M. Seitz, A. Karl, P. Hermanek, and N. Lack Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a peospective multicenter study J Urol 177 2007 1419 1422 (Pubitemid 46436004)
52. E. Suer, I. Gotce, O. Yaman, and O. Gögüs Open prostatectomy is still a valid option for large prostates: a high-volume, single-center experience Urology 72 2008 90 94